{"id":8876,"date":"2026-02-25T09:00:23","date_gmt":"2026-02-25T14:00:23","guid":{"rendered":"https:\/\/www.zeusinc.com\/?p=8876"},"modified":"2026-02-25T09:00:23","modified_gmt":"2026-02-25T14:00:23","slug":"what-oem-conversations-are-revealing-about-the-future-of-catheter-innovation","status":"publish","type":"post","link":"https:\/\/www.zeusinc.com\/blog\/2026\/02\/25\/what-oem-conversations-are-revealing-about-the-future-of-catheter-innovation\/","title":{"rendered":"What OEM Conversations are Revealing About the Future of Catheter Innovation"},"content":{"rendered":"<p>After a lot of recent conversations with OEM teams, one thing is clear to me: the way we think about catheter materials is changing.<\/p>\n<p>For decades, fluoropolymers have set the benchmark for catheter performance. They\u2019ve enabled incredible progress and earned their place in the industry. That history matters. But what I\u2019m hearing more and more is that performance alone isn\u2019t the only question anymore.<\/p>\n<p>OEM teams are being asked to think further ahead. They\u2019re balancing performance, long-term confidence, sustainability considerations, and supply chain realities, all at the same time. And they\u2019re trying to do it without slowing innovation down or increasing risk.<\/p>\n<p>That\u2019s not a small shift. That\u2019s a structural one.<\/p>\n<h4><strong>The Conversation Is Broader Now<\/strong><\/h4>\n<p>No one is walking away from high performance. If anything, expectations are higher than ever. What\u2019s changed is the lens.<\/p>\n<p>Customers want materials they can build on. Materials that won\u2019t force them to rethink their strategy two or three years down the road. Materials that align with where the industry is heading, not just where it\u2019s been.<\/p>\n<p>In the past, those priorities often felt like trade-offs. Today, there\u2019s a growing appetite to eliminate those trade-offs altogether.<\/p>\n<h4><strong>Why Platform Thinking Matters<\/strong><\/h4>\n<p>One thing that\u2019s really stood out to me is how much momentum there is around platform-based approaches.<\/p>\n<p>Instead of asking, \u201cCan this solve one problem?\u201d teams are asking, \u201cCan this support our roadmap?\u201d That\u2019s a very different conversation.<\/p>\n<p>Platform thinking gives OEMs room to engage early, test new ideas, and learn without having to re-engineer everything they already know. From a commercial perspective, that early engagement creates options. And options create confidence.<\/p>\n<p>First movers don\u2019t wait until the path is perfectly clear. They move early, learn quickly, and help shape where the market goes next.<\/p>\n<h4><strong>Sustainability Is Part of the Long-Term View<\/strong><\/h4>\n<p>Another consistent theme is sustainability. Not as a headline. Not as a regulatory reaction. But as part of long-term planning.<\/p>\n<p>Teams are thinking about material choices in the context of supply chain continuity, environmental priorities, and future expectations. They\u2019re asking, \u201cWill this still make sense five or ten years from now?\u201d<\/p>\n<p>That\u2019s a healthy shift. And it reinforces the need for material platforms that are built with longevity in mind.<\/p>\n<h4><strong>Looking Ahead<\/strong><\/h4>\n<p>For me, this isn\u2019t about replacing one material with another. It\u2019s about expanding what\u2019s possible.<\/p>\n<p>When you combine performance, long-term confidence, and forward-looking design, you unlock a different kind of innovation. One that\u2019s more intentional. More resilient. And ultimately more competitive.<\/p>\n<p>The momentum I\u2019m seeing right now tells me the industry is ready for that shift. And I\u2019m excited about the conversations still to come.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>After a lot of recent conversations with OEM teams, one thing is clear to me: the way we think about catheter materials is changing. For decades, fluoropolymers have set the benchmark for catheter performance. They\u2019ve enabled incredible progress and earned their place in the industry. That history matters. But what I\u2019m hearing more and more&#8230;<\/p>\n","protected":false},"author":27,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[29],"tags":[],"class_list":["post-8876","post","type-post","status-publish","format-standard","hentry","category-medical"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.zeusinc.com\/wp-json\/wp\/v2\/posts\/8876","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.zeusinc.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.zeusinc.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.zeusinc.com\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/www.zeusinc.com\/wp-json\/wp\/v2\/comments?post=8876"}],"version-history":[{"count":0,"href":"https:\/\/www.zeusinc.com\/wp-json\/wp\/v2\/posts\/8876\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.zeusinc.com\/wp-json\/wp\/v2\/media?parent=8876"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.zeusinc.com\/wp-json\/wp\/v2\/categories?post=8876"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.zeusinc.com\/wp-json\/wp\/v2\/tags?post=8876"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}